BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1660234)

  • 1. Synthetic organic ligands active at voltage-gated calcium channels.
    Triggle DJ; Hawthorn M; Gopalakrishnan M; Minarini A; Avery S; Rutledge A; Bangalore R; Zheng W
    Ann N Y Acad Sci; 1991; 635():123-38. PubMed ID: 1660234
    [No Abstract]   [Full Text] [Related]  

  • 2. [Voltage-dependent L-type calcium channels--inhibition, function and modulation].
    Schleifer KJ
    Pharm Unserer Zeit; 1997 Jul; 26(4):179-86. PubMed ID: 9411449
    [No Abstract]   [Full Text] [Related]  

  • 3. Voltage-dependent calcium channels--beyond dihydropyridine antagonists.
    Snutch TP; Sutton KG; Zamponi GW
    Curr Opin Pharmacol; 2001 Feb; 1(1):11-6. PubMed ID: 11712528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of 1,4-dihydropyridines with ion channels].
    Veizerová L; Svetlík J; Kettmann V
    Ceska Slov Farm; 2008 Apr; 57(2):58-62. PubMed ID: 18578414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and functional characteristics of dihydropyridine-sensitive and -insensitive calcium channel proteins.
    Dascal N
    Biochem Pharmacol; 1990 Sep; 40(6):1171-8. PubMed ID: 2169741
    [No Abstract]   [Full Text] [Related]  

  • 6. Fast activation of dihydropyridine-sensitive calcium channels of skeletal muscle. Multiple pathways of channel gating.
    Ma J; González A; Chen R
    J Gen Physiol; 1996 Sep; 108(3):221-32. PubMed ID: 8882865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical and pharmacological characterization of voltage-gated calcium currents in turtle auditory hair cells.
    Schnee ME; Ricci AJ
    J Physiol; 2003 Jun; 549(Pt 3):697-717. PubMed ID: 12740421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels.
    Catterall WA; Striessnig J; Snutch TP; Perez-Reyes E;
    Pharmacol Rev; 2003 Dec; 55(4):579-81. PubMed ID: 14657414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.
    Catterall WA; Perez-Reyes E; Snutch TP; Striessnig J
    Pharmacol Rev; 2005 Dec; 57(4):411-25. PubMed ID: 16382099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pharmacology of high voltage-activated calcium channels.
    Doering CJ; Zamponi GW
    J Bioenerg Biomembr; 2003 Dec; 35(6):491-505. PubMed ID: 15000518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depolarization as a regulatory signal at voltage-gated calcium channels.
    Triggle DJ
    Zhongguo Yao Li Xue Bao; 1996 May; 17(3):193-6. PubMed ID: 9812732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and voltage-clamp studies of methyl 1,4-dihydro-2, 6-dimethyl-5-nitro-4-(benzofurazanyl)pyridine-3-carboxylate racemates and enantiomers and of their benzofuroxanyl analogues.
    Visentin S; Amiel P; Fruttero R; Boschi D; Roussel C; Giusta L; Carbone E; Gasco A
    J Med Chem; 1999 Apr; 42(8):1422-7. PubMed ID: 10212128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new type of Ca-channel modulation by a novel class of 1,4-dihydropyridines.
    Bechem M; Goldmann S; Gross R; Hallermann S; Hebisch S; Hütter J; Rounding HP; Schramm M; Stoltefuss J; Straub A
    Life Sci; 1997; 60(2):107-18. PubMed ID: 9000116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of presynaptic calcium channels at the squid giant synapse: neither T-, L- nor N-type.
    Charlton MP; Augustine GJ
    Brain Res; 1990 Aug; 525(1):133-9. PubMed ID: 2173959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockers of Ca2+ channels in the plasmalemma of perfused Characeae cells.
    Zherelova OM; Grishchenko VM; Chaylakhyan LM
    Comp Biochem Physiol Pharmacol Toxicol Endocrinol; 1994 Mar; 107(3):475-80. PubMed ID: 8061954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ channel ligands: structure-function relationships of the 1,4-dihydropyridines.
    Triggle DJ; Langs DA; Janis RA
    Med Res Rev; 1989; 9(2):123-80. PubMed ID: 2654521
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular pharmacology of voltage-gated calcium channels.
    Triggle DJ
    Ann N Y Acad Sci; 1994 Dec; 747():267-81. PubMed ID: 7847676
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzymatic gating of voltage-activated calcium channels.
    Armstrong DL; Rossier MF; Shcherbatko AD; White RE
    Ann N Y Acad Sci; 1991; 635():26-34. PubMed ID: 1660238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels.
    Triggle DJ
    Mini Rev Med Chem; 2003 May; 3(3):215-23. PubMed ID: 12570837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.